Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Returns
Return on equity-85.7%-1.7pp-73.7%+25.8pp-95.4%-16.9pp-107.6%-44.6pp-84%-18.3pp
Return on assets-59.7%+11.2pp-52%+27.8pp-72.7%-7.2pp-80.6%-25.4pp-70.9%-13.5pp
Return on invested capital-147.2%+25.0pp-129.2%+9.1pp-130%-19.4pp-153.2%-46.0pp-172.1%-24.3pp
Liquidity
Current ratio15.1×+10.0×14.2×+8.9×6.4×-0.1×4.2×-5.1×5.1×-6.9×
Quick ratio15.1×+10.0×14.2×+8.9×6.4×-0.1×4.2×-5.1×5.1×-6.9×
Cash ratio4.2×+1.6×4.9×+3.1×+0.2×2.2×0.0×2.6×-3.3×
Leverage
Debt-to-equity-0.1×0.0×0.2×+0.1×0.4×+0.3×0.1×0.0×
Debt-to-assets0.0×0.0×0.1×+0.1×0.2×+0.2×0.1×0.0×
Interest coverage-84.7×-108.9×
Per Share
Book value per share$3.75+93.9%$4.94+100%$2.20-23.0%$1.35-64.0%$1.93-56.6%
Valuation
Market capitalization$6.25B+816%$5.45B+533%$2.01B+69.7%$824.32M-10.6%$681.96M+6.1%
Enterprise value$6.02B+951%$5.16B+560%$1.94B+76.0%$757.38M-11.1%$573.05M+28.7%
Price / book10.3×+7.2×8.6×+5.2×6.6×+2.9×5.3×+2.8×3.1×+1.6×
Free cash flow yield-4.6%+28.1pp-4.9%+19.3pp-12.3%+4.0pp-28.5%-9.2pp-32.7%-6.5pp
Earnings yield-5.7%+33.8pp-6%+23.7pp-14.7%+5.8pp-34.5%-9.8pp-39.5%-6.5pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Cogent Biosciences, Inc.'s ratios come from?
Every ratio is computed from Cogent Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.